Literature DB >> 10408182

Strategies for cohort sampling under the Cox proportional hazards model, application to an AIDS clinical trial.

S Kim1, V De Gruttola.   

Abstract

In some studies that relate covariates to times of failure it is not feasible to observe all covariates for all subjects. For example, some covariates may be too costly in terms of time, money, or effect on the subject to record for all subjects. This paper considers the relative efficiencies of several designs for sampling a portion of the cohort on which the costly covariates will be observed. Such designs typically measure all covariates for each failure and control for covariates of lesser interest. Control subjects are sampled either from "risk sets" at times of observed failures or from the entire cohort. A new design in which the sampling probability for each individual depends on the amount of information that the individual can contribute to estimated coefficients is shown to be superior to other sampling designs under certain conditions. Primary focus of our designs is on time-invariant covariates, but some methods easily generalize to the time-varying setting. Data from a study conducted by the AIDS Clinical Trials Group are used to illustrate the new sampling procedure and to explore the relative efficiency of several sampling schemes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10408182     DOI: 10.1023/a:1009601512314

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  9 in total

1.  Designs for synthetic case-control studies in open cohorts.

Authors:  J M Robins; R L Prentice; D Blevins
Journal:  Biometrics       Date:  1989-12       Impact factor: 2.571

2.  Likelihood analysis of multi-state models for disease incidence and mortality.

Authors:  J D Kalbfleisch; J F Lawless
Journal:  Stat Med       Date:  1988 Jan-Feb       Impact factor: 2.373

3.  More on "Biased selection of controls for case-control analyses of cohort studies".

Authors:  J M Robins; M H Gail; J H Lubin
Journal:  Biometrics       Date:  1986-06       Impact factor: 2.571

4.  On the design of synthetic case-control studies.

Authors:  R L Prentice
Journal:  Biometrics       Date:  1986-06       Impact factor: 2.571

5.  Synthetic retrospective studies and related topics.

Authors:  N Mantel
Journal:  Biometrics       Date:  1973-09       Impact factor: 2.571

6.  Nonparametric estimation of relative mortality from nested case-control studies.

Authors:  O Borgan; B Langholz
Journal:  Biometrics       Date:  1993-06       Impact factor: 2.571

7.  Biased selection of controls for case-control analyses of cohort studies.

Authors:  J H Lubin; M H Gail
Journal:  Biometrics       Date:  1984-03       Impact factor: 2.571

8.  The predictive value of changes in serologic and cell markers of HIV activity for subsequent clinical outcome in patients with asymptomatic HIV disease treated with zidovudine.

Authors:  M A Jacobson; V De Gruttola; M Reddy; J M Arduino; S Strickland; R C Reichman; J A Bartlett; J P Phair; M S Hirsch; A C Collier
Journal:  AIDS       Date:  1995-07       Impact factor: 4.177

9.  Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.

Authors:  P A Volberding; S W Lagakos; M A Koch; C Pettinelli; M W Myers; D K Booth; H H Balfour; R C Reichman; J A Bartlett; M S Hirsch
Journal:  N Engl J Med       Date:  1990-04-05       Impact factor: 91.245

  9 in total
  3 in total

1.  Influence function based variance estimation and missing data issues in case-cohort studies.

Authors:  S D Mark; H Katki
Journal:  Lifetime Data Anal       Date:  2001-12       Impact factor: 1.588

2.  Variation in the selenoprotein S gene locus is associated with coronary heart disease and ischemic stroke in two independent Finnish cohorts.

Authors:  Mervi Alanne; Kati Kristiansson; Kirsi Auro; Kaisa Silander; Kari Kuulasmaa; Leena Peltonen; Veikko Salomaa; Markus Perola
Journal:  Hum Genet       Date:  2007-07-20       Impact factor: 4.132

3.  Case-cohort design in practice - experiences from the MORGAM Project.

Authors:  Sangita Kulathinal; Juha Karvanen; Olli Saarela; Kari Kuulasmaa
Journal:  Epidemiol Perspect Innov       Date:  2007-12-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.